WST Q3 Earnings Preview: Will HVP Strength Offset Vantage Weakness?
West Declares Quarterly Dividend
West Pharmaceutical Stock Gains 36.1% YTD: What's Behind the Rally?
TD Cowen Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $420
West to Host Third-Quarter 2026 Conference Call
West Pharmaceutical Services Needs Faster Earnings Growth To Justify Its Price
West Pharmaceutical Services (WST) Stock Could Be 17% Overvalued As Cash Flow Falls Short
Barclays Maintains Overweight on West Pharmaceutical Servs, Raises Price Target to $440
West Pharma: Still A Buy, But Expectations Are Rising
What to Expect From West Pharmaceutical Services' Next Quarterly Earnings Report
West to Highlight Industry Leadership in Packaging and Containment at CPHI Worldwide
Drug Development Inputs & Services Stocks Q2 Highlights: West Pharmaceutical Services (NYSE:WST)
Josh Brown's 'Best Stocks in the Market:' West Pharmaceutical Services
West Pharmaceutical Poised to See EPS Upside to Current 2027 Wall Street Estimates, Morgan Stanley Says
Morgan Stanley Upgrades West Pharmaceutical Servs to Overweight, Raises Price Target to $400
Layoffs, Cyber Disruptions, Annex 1 Upgrades Might Change The Case For Investing In West (WST)
What Is Drawing Attention To West Pharmaceutical Services (WST)?
Is West Pharmaceutical Services Stock Outperforming the Nasdaq?
West Pharmaceutical Services, Inc. (WST) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
West Pharmaceutical Services, Inc. (WST) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.